Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.

Event Agenda

Chair & Emcee: Dr. Andrew Plump, President of R&D, Takeda (9th year)

Super Session: Honoring Dr. Stelios Papadopoulos, Chair of the Board, Exelixis with the Distinguished Service Award (5th award in 19 years).

Time

Topic

8:15 AM – 8:45 AM

Registration and Networking

8:45 AM – 8:55 AM

Welcome address: Karun Rishi, President, USAIC

Opening comments: Dr Andrew Plump, President of Research & Development, Takeda

8:55 AM – 9:40 AM

Panel: BioPharma- Measures for Unpredictable Times

 

Panelists:

Christopher Viehbacher, President & CEO, Biogen
Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
Sanat Chattopadhyay, President- Manufacturing, Merck & Co.
Dr. Susan Hockfield, President Emerita, Massachusetts Institute of Technology (MIT)

Moderator:
Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

9:40 AM – 10:25 AM

Panel: Rare & Neuro Diseases

 

Panelists:

Daphne Zohar, Founder & Chief Executive Officer, Seaport Therapeutics
Dr. Fiona Elwood, Vice President, Neurodegeneration DAS, J&J Innovative Medicine
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen
Dr. Nancy Andrews, Executive Vice President & CSO, Boston Children’s Hospital
Dr. Zandy Forbes, President & CEO, MeiraGTx

Moderator:
Dr. Steve Uden, Co-Founder & CEO, Rallybio

10:25 AM – 10:55 AM

Networking Break

10:55 AM – 11:40 AM

Panel: BioPharma Investment Priorities

 

Panelists:

Dr. Francesco De Rubertis, Co-founder & Partner, Medicxi
Dr. Kris Jenner, Co-Founder & Managing Member, Rock Springs Capital
Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments
Dr. Stephen Knight, President & Senior Managing Partner, F-Prime Capital

Moderator:
Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis, Inc.

11:40 AM – 12:25 PM

Panel: Clinical Trials Opportunities in India

 

Panelists:

Badhri Srinivasan, Executive Chairman, Unilabs
Dr. Christoph Koenen, Head of Clinical Development & Operations, Pharma R&D, Bayer
Dinkar Saran, Partner- Pharma and Life Sciences Operations, PwC
Peyton Howell, Chief Executive Officer, Parexel
Dr. Sarah Sheikh, Head of Global Development, Takeda

Moderator:
Peter Ronco, Chief Executive Officer, Emmes

12:25 PM – 1:25 PM

Lunch

1:25 PM – 2:10 PM

Panel: Oncology

 

Panelists:

Dr. Michael Morrissey, President & CEO, Exelixis
Dr. Paul-Peter Tak, President & CEO, Candel Therapeutics
Dr. Steve Harr, President & CEO, Sana Biotechnology
Dr. Sam Waksal, Founder, Chairman & CEO, Graviton Biosciences
Dr. Toni Choueiri, Director, Genitourinary (GU) Oncology, Dana-Farber Cancer Institute

Moderator:
Dr. Najat Khan, Chief R&D and Commercial Officer, Recursion

2:10 PM – 2:55 PM

Panel: R&D strategies in an era of unprecedented uncertainty and opportunity

 

Panelists:

Dr. Andrew Plump, President of Research & Development, Takeda
Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals
Dr. Maria Freire, Principal, The Freire Group
Dr. Mathai Mammen, Chairman & CEO, Parabilis Medicines

Moderator:
Dr. Kush Parmar, Managing Partner, 5AM Ventures

2:55 PM – 3:25 PM

Networking Break

3:25 PM – 4:10 PM

Panel: Digital & Data Science in Healthcare

 

Panelists:

Dr. Belen Fraile, Chief R&D Data Science Officer, Johnson & Johnson Innovative Medicine
Dr. Dina Katabi, Professor of Computer Science, Massachusetts Institute of Technology (MIT)
Dr. Nicole Glazer, Senior Vice President R&D Data, Takeda
Parag Saxena, Co-Founder & Managing Partner, Vedanta Capital
Dr. Paul Burton, Chief Medical Officer, Amgen

Moderator:
Sastry Chilukuri, Chairman & CEO, Emmes Group

4:10 PM – 4:15 PM

Closing Remarks: Dr Andrew Plump, President of Research & Development, Takeda

4:15 PM – 4:50 PM

Honouring Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis, Inc. with the
Distinguished Service Award

 

Tributes by:
Dr. Maria Freire, Principal, The Freire Group
Dr. Francesco De Rubertis, Co-founder & Partner, Medicxi
Dr. Sam Waksal, Founder, Chairman & CEO, Graviton Biosciences
Paris Panayiotopoulos, Senior Managing Director, Blackstone Life Sciences
Christopher Viehbacher, President & CEO, Biogen

4:50 PM – 5:00 PM

BioPharma Sisterhood Group Photo

5:00 PM – 6:00 PM

Networking Reception

*Program and Speakers subject to change
Please keep your cell phone in silent mode

Click here to download a PDF of this agenda.